13343-63-0 Usage
Description
BENZYL 2-ACETAMIDO-4,6-O-BENZYLIDENE-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE is a white solid that serves as a synthetic intermediate in the field of carbohydrate and oligosaccharide synthesis. It is a complex carbohydrate derivative with potential applications in various industries due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
BENZYL 2-ACETAMIDO-4,6-O-BENZYLIDENE-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE is used as a synthetic intermediate for the development of new pharmaceutical compounds, particularly in the synthesis of complex carbohydrates and oligosaccharides. Its unique structure allows for the creation of novel drug candidates with potential therapeutic applications.
Used in Chemical Research:
In the field of chemical research, BENZYL 2-ACETAMIDO-4,6-O-BENZYLIDENE-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE is used as a key intermediate for the synthesis of various complex carbohydrate structures. Researchers can utilize this compound to explore new chemical reactions and develop innovative synthetic pathways for carbohydrate chemistry.
Used in Material Science:
BENZYL 2-ACETAMIDO-4,6-O-BENZYLIDENE-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE may also find applications in material science, particularly in the development of advanced materials with unique properties. Its complex structure can be used to create new materials with potential applications in various industries, such as electronics, energy, and biotechnology.
Used in Food Industry:
In the food industry, BENZYL 2-ACETAMIDO-4,6-O-BENZYLIDENE-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE can be used as a synthetic intermediate for the development of new additives, flavor enhancers, or sweeteners. Its unique chemical properties may contribute to the creation of innovative products with improved taste, texture, or shelf life.
Used in Cosmetics Industry:
BENZYL 2-ACETAMIDO-4,6-O-BENZYLIDENE-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE may also have potential applications in the cosmetics industry, where it can be used as a synthetic intermediate for the development of new skincare or hair care products. Its unique properties could be harnessed to create innovative formulations with enhanced efficacy and performance.
Check Digit Verification of cas no
The CAS Registry Mumber 13343-63-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,4 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 13343-63:
(7*1)+(6*3)+(5*3)+(4*4)+(3*3)+(2*6)+(1*3)=80
80 % 10 = 0
So 13343-63-0 is a valid CAS Registry Number.
InChI:InChI=1/C22H25NO6/c1-14(24)23-18-19(25)20-17(13-27-21(29-20)16-10-6-3-7-11-16)28-22(18)26-12-15-8-4-2-5-9-15/h2-11,17-22,25H,12-13H2,1H3,(H,23,24)/t17-,18-,19-,20-,21+,22+/m1/s1
13343-63-0Relevant articles and documents
Sugar derived alkamine catalytic imine reduction method
-
Paragraph 0043; 0044; 0045, (2016/10/07)
The invention discloses a method used for catalytic reduction of imine with saccharide-derivatized amino alcohol. According to the method, imine is taken as a substrate. The method comprises following steps: 1) imine and saccharide-derivatized amino alcohol are dissolved in an organic solvent I, wherein molar ratio of imine to saccharide-derivatized amino alcohol ranges from 100:1-20; 2) trichlorosilane with 1.5 to 5 times equivalent weights is added into a solution obtained via step 1) dropwise, an obtained mixture is stirred and reacted for 12 to 36h at a temperature of -20 to 40 DEG C, and a saturated sodium bicarbonate solution is used for quenching; 3) a material obtained via step 2) is extracted with an organic solvent II, and is subjected to column chromatography isolation so as to obtain amine compounds.
Phosphoramidates of monosaccharides
-
Page/Page column 29, (2012/07/14)
The present invention relates novel phosphoramidates of monosaccharides of formula (I), wherein R1 is a monosaccharide group selected from A and B; R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16 and X are as defined herein. Preferably X is -O-. The present invention also provides processes for the production of compounds of formula (I), pharmaceutical compositions comprising these compounds, as well as to the use thereof in medical therapy, preferably in the treatment of osteoarthritis. wherein: R1 is selected from A and B,
PHOSPHORAMIDATES OF MONOSACCHARIDES
-
Page/Page column 45, (2012/08/27)
The present invention relates novel phosphorainidates of monosaccharides of formula (I), wherein R1 is a monosaccharide group selected from A and B: R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16 and X are as defined herein. Preferably X is -0-. The present invention also provides processes for the production of compounds of formula (I), pharmaceutical compositions comprising these compounds, as well as to the use thereof in medical therapy, preferably in the treatment of osteoarthritis. Formula (I) wherein: R1 is selected from A and B.